Related Experiment Video
Updated: Jul 3, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies
Yujinpeng Hao1, Jun Shao1, Naqi Lian2
1The First Clinical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Abstract:
Eukaryotic translation initiation factor 3 subunit F (eIF3f) is a critical component of the eIF3 complex and plays a pivotal role in diverse biological processes, including cell proliferation, apoptosis, adhesion, and transcriptional regulation. Recent studies have revealed that eIF3f is aberrantly expressed in multiple malignancies and exhibits a striking context-dependent functional profile. In solid tumors such as hepatocellular carcinoma (HCC), colorectal cancer (CRC), and prostate cancer (PCa), elevated eIF3f expression correlates with poor patient prognosis, indicating an oncogenic role. Conversely, in pancreatic cancer (PC) and melanoma (MM), reduced or absent eIF3f expression promotes tumor progression, suggesting a tumor-suppressive function. This functional plasticity indicates that eIF3f is not a simple oncogenic driver but rather a molecular hub that integrates diverse cellular signals. This review systematically delineates the structural characteristics and biological functions of eIF3f, summarizing its expression patterns and underlying molecular mechanisms across various malignancies. Building on this, we propose an integrated mechanistic framework that attributes the functional plasticity of eIF3f to differential upstream signaling networks, heterogeneity in post-translational modification profiles, and the remodeling status of the tumor microenvironment (TME). Furthermore, we critically evaluate the strength of evidence supporting eIF3f as a diagnostic and prognostic biomarker, identify methodological bottlenecks and translational challenges in current targeting strategies, and outline priority research directions, including elucidating the structural biological basis of its functional plasticity and developing context-specific intervention strategies. By integrating mechanistic insights with clinical relevance, this review aims to establish a conceptually coherent and mechanistically testable theoretical framework for eIF3f research, guiding the design of precision stratified therapeutic approaches and facilitating its substantive translation from basic research to clinical application.
Insights
Eukaryotic translation initiation factor 3 subunit F (eIF3f) has dual roles in cancer, acting as an oncogene in some cancers and a tumor suppressor in others. Understanding its context-dependent functions is key for developing targeted therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Eukaryotic translation initiation factor 3 subunit F (eIF3f) is integral to the eIF3 complex, influencing cell proliferation, apoptosis, and transcription.
- Aberrant eIF3f expression is observed in various cancers, with a context-dependent role in tumor progression.
Purpose of the Study:
- To systematically review the structural characteristics, biological functions, and expression patterns of eIF3f across malignancies.
- To propose a mechanistic framework for eIF3f's functional plasticity and evaluate its potential as a biomarker.
- To identify challenges and future directions for eIF3f-targeted cancer therapies.
Main Methods:
- Systematic literature review and analysis of eIF3f's role in different cancer types.
- Integration of data on eIF3f expression, post-translational modifications, and tumor microenvironment interactions.
- Critical evaluation of diagnostic/prognostic biomarker potential and therapeutic targeting strategies.
Main Results:
- eIF3f exhibits oncogenic roles in hepatocellular carcinoma, colorectal cancer, and prostate cancer, but tumor-suppressive functions in pancreatic cancer and melanoma.
- Functional plasticity is attributed to differential upstream signaling, post-translational modifications, and tumor microenvironment remodeling.
- Evidence for eIF3f as a biomarker is variable, with challenges in current therapeutic strategies.
Conclusions:
- eIF3f's dual role necessitates context-specific understanding for effective therapeutic strategies.
- Further research into eIF3f's structural biology and context-dependent mechanisms is crucial.
- Developing precision, stratified therapeutic approaches for eIF3f is a priority for clinical translation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
